Alex Sankin

Albert Einstein College of Medicine — United States

Medicine · Health Sciences

17h-index811citations50works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(23), Urinary and Genital Oncology Studies(18), Prostate Cancer Diagnosis and Treatment(14), Prostate Cancer Treatment and Research(11), Cancer Immunotherapy and Biomarkers(7)

Publications50 total

Adopting the Fruits of Innovation: Using New Drugs to Treat Nonmuscle-Invasive Bladder Cancer
The Journal of Urology·2025
BEYOND THE TUMOR: EXPLORING THE FINANCIAL TOXICITY OF NON-MUSCLE INVASIVE BLADDER CANCER IN A DIVERSE, URBAN POPULATION
Urologic Oncology Seminars and Original Investigations·2025
Variation in Clinically Significant Prostate Cancer on Fusion Biopsy of PI-RADS 3–5 Lesions Based on Ethnicity
American Journal of Men s Health·2025Open Access
Health-related Internet Use Among New Urology Clinic Patients
Urology·2024· 2 cited
Low-grade Urothelial Carcinoma Recurs at a Tempo that Naturally Accelerates Over Time
Urology·2024· 1 citedOpen Access
OUTCOMES OF TRIMODAL THERAPY FOR CT2-3 UROTHELIAL CARCINOMA IN A MULTIETHNIC, DIVERSE POPULATION
Urologic Oncology Seminars and Original Investigations·2024
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer
BMC Cancer·2023· 5 citedOpen Access
A Procedural Checklist for Transurethral Resection of Bladder Tumors (TURBT) Enhances Operative Dictation and Assesses Surgeon Accuracy of Tumor Characteristic Predictions
Bladder Cancer·2023· 4 citedOpen Access
AUTHOR REPLY
Urology·2023
A Phase 1b/2 Study of Atezolizumab with or Without Bacille Calmette-Guérin in Patients with High-risk Non–muscle-invasive Bladder Cancer
European Urology Oncology·2023· 30 citedOpen Access
Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort
Urologic Oncology Seminars and Original Investigations·2023· 1 cited
Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non–muscle-Invasive Bladder Cancer
Clinical Genitourinary Cancer·2022· 8 cited
The Impact of Holistic Review of Urology Residency Applications on Selection for Interview During the COVID-19 Pandemic
Urology·2022· 17 citedOpen Access
Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2022· 9 citedOpen Access
Editorial Comment
The Journal of Urology·2022
Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy
Clinical Genitourinary Cancer·2022· 3 cited
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma
Clinical Genitourinary Cancer·2022· 25 citedOpen Access
PD26-08 LOW-GRADE UROTHELIAL CARCINOMA RECURS AT A TEMPO THAT NATURALLY ACCELERATES FROM ADAGIO TO ALLEGRO
The Journal of Urology·2022
MP31-15 TELEUROLOGY: EXPANDING HORIZONS TO INPATIENT ECONSULTS
The Journal of Urology·2022
Response and Outcomes to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Based on Prior Intravesical Bacillus Calmette-Guerin
Clinical Genitourinary Cancer·2021· 6 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Ahmed Aboumohamed(12), Benjamin A. Gartrell(10), Evan Kovac(10), Herbert Lepor(9), Kara Watts(9), Ali Raza Khaki(8), Leonidas Nikolaos Diamantopoulos(8), Mehmet Asım Bilen(8), Rafael Morales‐Barrera(8), Michael Devitt(8), Ariel Ann Nelson(8), Christopher Hoimes(8), Alejo Rodríguez‐Vida(8), David J. Pinato(8), Monika Joshi(8), Sandy Liu(8), Lucía Alonso Buznego(8), Ignacio Durán(8), Jure Murgić(8), Abhishek Tripathi(8)